Locations:

Interventional Cardiology

May 16, 2024/Heart, Vascular and Thoracic/Congenital Disease

TAVR: An Important Option for Adults With Congenital Heart Disease

Cleveland Clinic case series demonstrates feasibility and safety in diverse patients

severe tricuspid regurgitation on an echocardiogram

May 13, 2024/Heart, Vascular and Thoracic/Heart Valve Disease

What to Expect Now That Transcatheter Tricuspid Valve Therapies Have Been Approved

Limited data and experience will translate to a cautious rollout

April 4, 2024/Heart, Vascular and Thoracic/Interventional Cardiology

Untreated Obstructive Coronary Artery Disease Safe in TAVR Recipients, Study Shows

Support for a TAVR-first approach in patients with concurrent valve and coronary disease

angiograms of a percutaneous coronary intervention

December 22, 2023/Heart, Vascular and Thoracic/Interventional Cardiology

Registry Study Shows Growth in Use of Carlino Technique for High-Complexity CTOs

While procedural success rates lag overall, they shine for retrograde crossing

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

October 24, 2023/Heart, Vascular and Thoracic/Interventional Cardiology

Concurrent TAVR and Watchman Placement Is Noninferior to TAVR Plus Medical Therapy for Atrial Fibrillation

Randomized WATCH-TAVR trial confirms safety of the combined procedures

23-HVI-4078311_chronic-total-occlusion_650x450

August 21, 2023/Heart, Vascular and Thoracic/Interventional Cardiology

Study Links Distal Target Vessel Quality With PCI Outcomes in Chronic Total Occlusion

Lower success rates, more hospital MACE seen with poor-quality distal targets

illustration of intracoronary brachytherapy

August 18, 2023/Cancer

Intracoronary Brachytherapy Shown to Be Viable Option for DES In-Stent Restenosis

Number of stent layers correlates with worse outcomes

January 18, 2023/Heart, Vascular and Thoracic/Interventional Cardiology

Simple Measures for Cath Lab Radiation Dose Reduction Significantly Lower Exposure

Cleveland Clinic experience is applicable to other laboratories

September 22, 2022/Heart, Vascular and Thoracic/Interventional Cardiology

PROTECTED TAVR Finds Reduced Rate of Disabling Stroke With Cerebral Embolic Protection

Results from largest randomized trial of the technology to date

July 1, 2022/Heart, Vascular and Thoracic/Interventional Cardiology

Coronary Sinus Reducing Device: A New Option for Refractory Angina May Soon Be at Hand

Pivotal COSIRA-II multicenter U.S. clinical trial is underway

BackPage 2 of 3Next